Pneumococcal disease and the role of conjugate vaccines

Microbial Drug Resistance

Volumn 5, Issue 2, 1999, Pages 147-157

  Klein, David L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; DIPHTHERIA TOXOID; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL MEMBRANE; BACTERIAL MENINGITIS; CLINICAL TRIAL; CONJUGATE; HUMAN; IMMUNE RESPONSE; OTITIS MEDIA; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; VACCINE PRODUCTION;

EID: 0032787846     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1999.5.147     Document Type: Review

References (7)

1. Acute Respiratory Infections. 1998. The forgotten pandemic. Int. J. Tuberc. Lung. Dis. 2:2-4.
2. Adams, W.G., K.A. Deaver, and S.L. Cochi. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. J.A.M.A. 269:221-226.
3. th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, p. 170.
4. Ahmed, F., M.C. Steinhoff, M.C. Rodriguez-Barradas, R.G. Hamilton, D.M. Muscher, and K.E. Nelson. 1996. Effect of human immunodeficiency virus type 1 infection on the antibody response to glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J. Infect. Dis. 173:83-90.
5. Baltimore, R. 1992. New challenges in the development of a conjugate pneumococcal vaccine. J.A.M.A. 268:3366-3367.
6. Berman, S. 1991. Epidemiology of acute respiratory infections in children of developing countries. Rev. Infect. Dis. 13:5454-5462.
7. Bisgard, K.M., A. Kao, J. Leake, P.M. Strebel, B.A. Perkins, and M. Wharton. 1998. Haemophilus influenzae invasive disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg. Infect. Dis. 4:229-237.